REAGENT NEONATAL ELISA

REAGENT NEONATAL ELISA
Catalog No. Product Name Intended Use Method Sample Type Controls included Test / Kit
E-GP-192B NEONATAL TSH Thyroid Stimulating Hormone ELISA DBS 2 levels 192
E-GP-480B     480
E-GP-2400B     2400
E-GQ-192 NEONATAL 17-OHP 17 Alpha-Hydroxyprogesterone ELISA DBS 2 levels 192
E-GQ-1920     1920
E-KR-192 NEONATAL IRT Cyctic Fibrosis ELISA DBS 2 levels 192
E-KR-480     480
E-TW-480 NEONATAL PKU Phenylalanine ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-TW-1920     1920
E-IZ-480 NEONATAL TOTAL GALACTOSE Total Galactose (Galactose and Galactose-1-Phosphate) ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-IZ-1920     1920
E-TX-480 NEONATAL G-6-PD Glucose-6-phosphate dehydrogenase ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-TX-1920     1920
E-IY-480 NEONATAL MSUD Maple Syrup Urine Disease ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-IY-1920     1920
E-KH-480 NEONATAL BTD Biotinidase Deficiency ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-KH-1920     1920

ZenTech S.A., Belgium

Newborn Screening Tests Using Dried Blood Spot Samples (DBS)

Usually, all newborns are routinely screened for certain genetic, metabolic, hormonal and functional disorders. Most of these birth defects have no immediate visible effects on a baby but, unless detected and treated early, can cause physical problems, mental retardation and, in some cases, death. Fortunately, most babies are given a clean bill of health when tested. However, a lot of babies are found to have metabolic disorders and in these cases, only an early diagnosis and proper treament can make the difference between healthy development and lifelong impairment. Many of the tests use a blood specimen taken before the baby leaves the hospital: the baby’s heel or finger is pricked to obtain a few drops of blood and blotted onto filter paper for laboratory analysis (Dried Boold Spot or DBS).

The diseases the newborns are routinely screened for are:

  • Endocrine disorders : Congenital hypothyroidism (TSH, Congenital Adrenal Hyperplasia (17-OHP))
  • Blood cell disorders : Glucose-6-phosphate-dehydrogenase deficiency (G6PD)
  • Inborn errors of carbohydrate metabolism : Galactosemia (TOTAL GALACTOSE)
  • Inborn errors of amino acid metabolism : Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD)
  • Genetic diseases and metabolic disorders : Cytic Fibrosis (IRT screening assay), Biotinidase deficiency (BTD screening assay)

service@setia-medika.co.id

support@setia-medika.co.id

0812 – 2000 – 6006
   

Related Information

Reagent Neonatal Elisa/IAEA - report - Newborn screening establishment.pdf
Reagent Neonatal Elisa/NBS-Worldwide.pdf
Events|Blog|Locations|News|e-Catalogue
© Copyright 2016 PT.Setia Medika.
All rights reserved.

REAGENT NEONATAL ELISA

REAGENT NEONATAL ELISA
Catalog No. Product Name Intended Use Method Sample Type Controls included Test / Kit
E-GP-192B NEONATAL TSH Thyroid Stimulating Hormone ELISA DBS 2 levels 192
E-GP-480B     480
E-GP-2400B     2400
E-GQ-192 NEONATAL 17-OHP 17 Alpha-Hydroxyprogesterone ELISA DBS 2 levels 192
E-GQ-1920     1920
E-KR-192 NEONATAL IRT Cyctic Fibrosis ELISA DBS 2 levels 192
E-KR-480     480
E-TW-480 NEONATAL PKU Phenylalanine ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-TW-1920     1920
E-IZ-480 NEONATAL TOTAL GALACTOSE Total Galactose (Galactose and Galactose-1-Phosphate) ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-IZ-1920     1920
E-TX-480 NEONATAL G-6-PD Glucose-6-phosphate dehydrogenase ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-TX-1920     1920
E-IY-480 NEONATAL MSUD Maple Syrup Urine Disease ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-IY-1920     1920
E-KH-480 NEONATAL BTD Biotinidase Deficiency ENZYMATIC COLORIMETRIC DBS 2 levels 480
E-KH-1920     1920

ZenTech S.A., Belgium

Newborn Screening Tests Using Dried Blood Spot Samples (DBS)

Usually, all newborns are routinely screened for certain genetic, metabolic, hormonal and functional disorders. Most of these birth defects have no immediate visible effects on a baby but, unless detected and treated early, can cause physical problems, mental retardation and, in some cases, death. Fortunately, most babies are given a clean bill of health when tested. However, a lot of babies are found to have metabolic disorders and in these cases, only an early diagnosis and proper treament can make the difference between healthy development and lifelong impairment. Many of the tests use a blood specimen taken before the baby leaves the hospital: the baby’s heel or finger is pricked to obtain a few drops of blood and blotted onto filter paper for laboratory analysis (Dried Boold Spot or DBS).

The diseases the newborns are routinely screened for are:

  • Endocrine disorders : Congenital hypothyroidism (TSH, Congenital Adrenal Hyperplasia (17-OHP))
  • Blood cell disorders : Glucose-6-phosphate-dehydrogenase deficiency (G6PD)
  • Inborn errors of carbohydrate metabolism : Galactosemia (TOTAL GALACTOSE)
  • Inborn errors of amino acid metabolism : Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD)
  • Genetic diseases and metabolic disorders : Cytic Fibrosis (IRT screening assay), Biotinidase deficiency (BTD screening assay)

service@setia-medika.co.id

support@setia-medika.co.id

0812 – 2000 – 6006
   

Related Information

Reagent Neonatal Elisa/IAEA - report - Newborn screening establishment.pdf
Reagent Neonatal Elisa/NBS-Worldwide.pdf
© Copyright 2016 PT.Setia Medika.
All rights reserved.